Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Wang, Lei ^a   Jiang, Dian Ming ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Buyang Huanwu Decoction; Cdk5; Inhibitor; Roscovitine; Spinal ischemia reperfusion

Indexed keywords

BUYANG HUANWU DECOCTION; CHINESE DRUG; CYCLIN DEPENDENT KINASE 5; NEUROPROTECTIVE AGENT; PROTEIN P25; PROTEIN P35; ROSCOVITINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; MALE; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SPINAL CORD ISCHEMIA;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; DRUGS, CHINESE HERBAL; HUMANS; ISCHEMIA; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPINE;

EID: 84887529496     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-309     Document Type: Article

References (24)

1. Connolly JE. Hume memorial lecture. Prevention of spinal cord complications in aortic surgery. Am J Surg 1998, 176(2):92-101. 10.1016/S0002-9610(98)00133-0, 9737610.
2. Gad MA, Saber A, Farrag S, Shams ME, Ellabban GM. Incidence, patterns, and factors predicting mortality of abdominal injuries in trauma patients. N Am J Med Sci 2012, 4(3):129-134. 10.4103/1947-2714.93889, 3309620, 22454826.
3. Bradbury EJ, McMahon SB. Spinal cord repair strategies: why do they work? nature reviews. Neuroscience 2006, 7:644-653.
4. Hao CZ, Wu F, Shen J, Lu L, Fu DL, Liao WJ, Zheng GQ. Clinical efficacy and safety of buyang huanwu decoction for acute ischemic stroke: a systematic review and meta-analysis of 19 randomized controlled trials. Evid Based Complement Alternat Med 2012, 2012:630124. 3491750, 23193426.
5. Wang L, Jiang DM. Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia/reperfusion injury in rats. J Ethnopharmacol 2009, 124:219-223. 10.1016/j.jep.2009.04.045, 19409971.
6. Zhao LD, Wang JH, Jin GR, Zhao Y, Zhang HJ. Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats-time window and mechanism. J Ethnopharmacol 2012, 140(2):339-44. 10.1016/j.jep.2012.01.026, 22306289.
7. Nwose EU, Ewing GW. Computer diagnosis in cardiology: oxidative stress hypothesis. N Am J Med Sci 2009, 1(5):220-5. 3364613, 22666699.
8. Eweka AO, Eweka A, Om'Iniabohs FAE. Histological studies of the effects of monosodium glutamate of the fallopian tubes of adult female Wistar rats. N Am J Med Sci 2010, 2:146-149. 3354428, 22624130.
9. Menn B, Bach S, Blevins TL, Campbell M, Meijer L, Timsit S. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. Plos One 2010, 5(8):e12117. 10.1371/journal.pone.0012117, 2920814, 20711428.
10. Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttila T. Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons. Neurosci Lett 2004, 368:181-185. 10.1016/j.neulet.2004.07.007, 15351445.
11. Utreras E, Maccioni R, Gonzalez-Billault C. Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells. Neuroscience 2009, 161:978-987. 10.1016/j.neuroscience.2009.04.002, 19362124.
12. Westergren H, Farooque M, Olsson Y, Holtz A. Spinal cord blood flow changes following systemic hypothermia and spinal cord compression injury: an experimental study in the rat using laser-Doppler flowmetry. Spinal Cord 2001, 39:74-84. 10.1038/sj.sc.3101127, 11402362.
13. Bu B, Li J, Davies P, Vincent I. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci 2002, 22:6515-6525.
14. Hallows JL, Chen K, DePinho RA, Vincent I. Decreased Cyclin-Dependent Kinase 5 (cdk5) Activity Is Accompanied by Redistribution of cdk5 and Cytoskeletal Proteins and Increased Cytoskeletal Protein Phosphorylation in p35 Null Mice. J Neurosci 2003, 23(33):10633-10644.
15. Johnson SH, Kraimer JM, Graeber GM. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits. Stroke 1993, 24(10):1547-53. 10.1161/01.STR.24.10.1547, 8378960.
16. Fan L, Wang K, Cheng B. Effects of Buyang Huanwu Decoction on and expressions of Bcl-2 and Bax ischemia-reperfusion injury in rabbits. J Tradi Chin Med 2006, 26:153-156.
17. Wei T, Chen C, Hou J, Xin W, Mori A. Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta 2000, 1498:72-79. 10.1016/S0167-4889(00)00078-1, 11042352.
18. Wang CH, Chou WY, Hung KS, Jawan B, Lu CN, Liu JK, Hung YP, Lee TH. Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin-induced nociceptive response in rats. Acta Pharmacol Sin 2005, 26(1):46-50. 10.1111/j.1745-7254.2005.00007.x, 15659113.
19. Lou J, Lenke LG, Ludwig FJ, O'Brien MF. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 1998, 36:683-90. 10.1038/sj.sc.3100632, 9800272.
20. Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol 2001, 2:749-759. 10.1038/35096019, 11584302.
21. Cheung ZH, Fu AK, Ip NY. Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 2006, 50:13-18. 10.1016/j.neuron.2006.02.024, 16600851.
22. Smith DS, Tsai LH. Cdk5 behind the wheel: a role in trafficking and transport?. Trends Cell Biol 2002, 12:28-36. 10.1016/S0962-8924(01)02181-X, 11854007.
23. Amin ND, Albers W, Pant HC. Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J Neurosci Res 2002, 67:354-362. 10.1002/jnr.10116, 11813240.
24. Zheng YL, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, Albers W, Grant P, Pant HC. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J 2005, 24:209-220. 10.1038/sj.emboj.7600441, 544899, 15592431.